SPRINGFIELD — For the parents of children with life-threatening allergies, every outing carries a level of anxiety that other families never have to consider. Senator Suzy Glowiak Hilton is easing that burden under a new law that will recognize all FDA-approved epinephrine treatments.
“Parents need that comfort knowing their child will have access to whatever form of epinephrine works best, whether they are at school, camp or an after school program,” said Glowiak Hilton (D-Western Springs). “Severe allergic reactions can happen at any time and any place, and can be a life or death situation.”
House Bill 3454 will update current Illinois statute — covering schools, law enforcement, after-school programs, camps, home health care and health insurance — to replace the outdated term "epinephrine injector" with "epinephrine delivery device." This change will align state law with the FDA-approved treatments that exist today.
Under the Glowiak Hilton law, the change will ensure institutions and caregivers across Illinois are not legally restricted to needle-based injectors when newer options, like the epinephrine nasal spray Neffy, are available and approved for use.
House Bill 3454 was signed into law Friday and takes effect Jan. 1.
